Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 28 (RPL12P28)

Target: RPL12P28
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L12 pseudogene 28 (RPL12P28) is a processed pseudogene relating to the functional ribosomal protein L12. As a pseudogene, RPL12P28 does not encode a functional protein or participate in cellular processes. It is listed in genetic databases as a non-coding genomic element, resulting from duplication or retrotransposition events involving the RPL12 gene. There is no evidence supporting a functional, biological, or therapeutic relevance for RPL12P28.

Other names: RPL12P28

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 28 (RPL12P28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 28 (RPL12P28).

Explore the full profile